Kazazian Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kazazian Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,479	Closed	-$586K	–	72
2019 Q1	$586K	Sell	3,479 -334	-9%	-$49.7K	0.81%	29
2018 Q4	$371K	Sell	3,813 -572	-13%	-$75K	0.5%	36
2018 Q3	$757K	Buy	4,385 +626	+17%	+$90.3K	0.71%	36
2018 Q2	$525K	Buy	+3,759	New	+$534K	0.48%	41

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Kazazian Asset Management's GWPH Position: Q2 2019 in Review

Kazazian Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 3,479 shares — an estimated $586K sold.

Kazazian Asset Management first reported a position in GWPH in Q2 2018 and held it in 4 quarters. The position peaked at $757K in Q3 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

Kazazian Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Kazazian Asset Management sold 3,479 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $586K.
Kazazian Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 4 quarters.
Kazazian Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $757K in Q3 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Kazazian Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.